Passa al contenuto
Merck

69732

Lithium mupirocin Supplement

suitable for microbiology,

Selectively inhibits the growth of lactic acid bacteria

Sinonimo/i:

Lithium mupirocin solution, Li-MUP, MUP supplement

Slide 1 of 1
Autenticati per visualizzare i prezzi riservati alla tua organizzazione & contrattuali

Scegli un formato

10 X 5 ML

264,00 €

10 X 25 ML

356,00 €

264,00 €

Per informazioni sulla disponibilità, contatta il Servizio Clienti.
Richiedi maggiori informazioni

Informazioni su questo articolo

Formula empirica (notazione di Hill):
C26H43LiO9
Numero CAS:
73346-79-9
Peso molecolare:
506.56
Numero MDL:
MFCD11977847
Codice UNSPSC:
41171614
ID PubChem:
329761909
NACRES:
NA.85

Documenti fondamentali

Visualizza tutta la documentazione

Vai a

Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti

agenzia

ISO 29981:2010

Livello qualitativo

100

Sterilità

sterile (Filtered and Aseptic Handled)
sterile

Stato

liquid

Durata

limited shelf life, expiry date on the label

applicazioni

environmental
food and beverages
microbiology

Temperatura di conservazione

2-8°C

Compatibilità

Lactobacillus spp.
Lactococcus spp.
Leuconostoc spp.
Streptococcus spp.

Stringa SMILE

[Li+].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)[C@H](O)[C@@H]2O

InChI

1S/C26H44O9.Li/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27;/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29);/q;+1/p-1/b16-13+;/t17-,18-,19-,20-,21-,24+,25-,26-;/m0./s1
XFIKMPRBSORKQP-JATHGWPISA-M

Categorie correlate

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 4

Questo articolo
PHR3421M38060001448923
Lithium mupirocin Supplement suitable for microbiology, Selectively inhibits the growth of lactic acid bacteria

Millipore

69732

Lithium mupirocin Supplement

Mupirocin Lithium certified reference material, pharmaceutical secondary standard

Supelco

PHR3421

Mupirocin Lithium

Mupirocin lithium European Pharmacopoeia (EP) Reference Standard

M3806000

Mupirocin lithium

Mupirocin lithium United States Pharmacopeia (USP) Reference Standard

USP

1448923

Mupirocin lithium

suitability

Lactobacillus spp., Leuconostoc spp., Lactococcus spp., Streptococcus spp.

suitability

-

suitability

-

suitability

-

application(s)

environmental
food and beverages, microbiology

application(s)

pharmaceutical

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

form

liquid

form

-

form

-

form

-

sterility

sterile (Filtered and Aseptic Handled)

sterility

-

sterility

-

sterility

-

storage temp.

2-8°C

storage temp.

-10 to -25°C

storage temp.

2-8°C

storage temp.

-

shelf life

limited shelf life, expiry date on the label

shelf life

-

shelf life

-

shelf life

-

Descrizione generale

Lithium mupirocin is isolated from Pseudomonas fluorescens. At lower concentrations, it has bacteriostatic characteristics, while at higher concentrations it is bacteriocidal. Mupirocin is active against gram-positive bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA), Lactobacilli, Lactococci, Streptococci and Leuconostocs. Mupirocin has been used to study mupirocin resistance in Mycoplasma bacteria. Mupirocin inhibits the isoleucyl-tRNA synthetase, which finally results in inhibition of protein and RNA synthesis. Mupirocin lithium salt is freely soluble in water.

Applicazioni

Lithium mupirocin supplement is used for selective enumeration of Bifidobacteria from fermented milk products along with the TOS-propionate agar according to ISO 29981:2010 and IDF 220:2010

Altre note

Composition:
(5ml, sufficient for 100 ml medium)
Mupirocin 5 mg
sterile distilled water 5.0 ml

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

WGK 2

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
BCCM4587
BCCJ9097
BCCH6039
BCCH0638
BCCG6315

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Variation, viability and validity of bifidobacteria in fermented milk products.
Raeisi, Shahram Naghizadeh, et al.
Food Control, 34, 691-697 (2013)
J Gilbart et al.
Antimicrobial agents and chemotherapy, 37(1), 32-38 (1993-01-01)
Mupirocin resistance in Staphylococcus aureus results from changes in the target enzyme, isoleucyl-tRNA synthetase (IRS). Twelve strains of S. aureus comprising four susceptible (MICs < or = 4 micrograms/ml), four intermediate level-resistant (MICs between 8 and 256 micrograms/ml), and four
Kristin A Seiberling et al.
International forum of allergy & rhinology, 3(2), 94-98 (2012-11-30)
Antibiotic irrigations are occasionally used during endoscopic sinus surgery when gross mucosal infection is present. These irrigations are thought to flush out pathogenic bacteria and decrease the bacterial load within the mucosal surfaces. This treatment, however, has not been studied
M Lepainteur et al.
The Journal of hospital infection, 83(4), 333-336 (2013-02-19)
In neonatal intensive care units, topical agents represent an increasing part of the infection control armamentarium. Fifty-one coagulase-negative staphylococci (CNS) isolated from catheter-associated bloodstream infections in very preterm neonates were investigated in this study: 41.2% exhibited decreased susceptibility to at
Sapna Mehta et al.
Clinical orthopaedics and related research, 471(7), 2367-2371 (2013-02-21)
Hospital-acquired infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are a source of morbidity and mortality. S. aureus is the most common pathogen in prosthetic joint infections and the incidence of MRSA is increasing. The purposes of this study were (1)
Visualizza tutti i documenti correlati

Contenuto correlato

Domande

Recensioni

Nessuna valutazione

Filtri attivi

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica